Global Genome Editing & Genome Engineering Market Growth (Status and Outlook) 2023-2029

Global Genome Editing & Genome Engineering Market Growth (Status and Outlook) 2023-2029

Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.

LPI (LP Information)' newest research report, the “Genome Editing & Genome Engineering Industry Forecast” looks at past sales and reviews total world Genome Editing & Genome Engineering sales in 2022, providing a comprehensive analysis by region and market sector of projected Genome Editing & Genome Engineering sales for 2023 through 2029. With Genome Editing & Genome Engineering sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genome Editing & Genome Engineering industry.

This Insight Report provides a comprehensive analysis of the global Genome Editing & Genome Engineering landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genome Editing & Genome Engineering portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genome Editing & Genome Engineering market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genome Editing & Genome Engineering and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genome Editing & Genome Engineering.

The global Genome Editing & Genome Engineering market size is projected to grow from US$ 3436.6 million in 2022 to US$ 6548.3 million in 2029; it is expected to grow at a CAGR of 9.6% from 2023 to 2029.

The CRISPR segment is estimated to grow at the highest CAGR during the forecast period.

This report presents a comprehensive overview, market shares, and growth opportunities of Genome Editing & Genome Engineering market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
CRISPR
TALEN
ZFN

Segmentation by application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated Dna Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics

Please note: The report will take approximately 2 business days to prepare and deliver.